Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
United States
Karmanos Cancer Institute, Detroit, Michigan Cleveland Clinic Taussig Cancer Center, Cleveland, Ohio Tennessee Oncology, PLLC, Nashville, Tennessee MD Anderson Cancer Center, Houston, Texas